Picture of HAMLET Pharma AB logo

HAMLET TO4 B HAMLET Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: HAMLET Pharma Updates On Alpha1H Treatment

Oct 11 (Reuters) - Hamlet Pharma AB  HAMLET.TE :
    * HAMLET PHARMA RELEASES FURTHER DATA FROM CLINICAL STUDY
    * THERE WERE NO SIDE EFFECTS RELATED TO ALPHA1H TREATMENT
    * WE CONCLUDE THAT INSTILLATION OF 1.7 MM OF ALPHA1H INTO
BLADDER
CAN BE REGARDED AS SAFE.

Source text for Eikon:  ID:nWkrbhRsvR 
Further company coverage:  HAMLET.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on HAMLET Pharma AB

See all news